By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
Płać wygodnie kartą, Klarną, Apple Pay lub Google Pay. Nie jesteś zadowolony? Zawsze masz 14-dniową gwarancję zwrotu pieniędzy. Więcej przeczytasz w naszych warunkach. Masz pytania? Napisz do nas na hello@memmo.org.
Memmo ułatwia naukę – gdziekolwiek jesteś na świecie. U nas znajdziesz podręczniki i sprytne narzędzia do nauki w jednym miejscu: streszczenia, quizy, podcasty i fiszki. A do tego Ted, Twój kumpel do nauki, który odpowie na wszystko, co Cię nurtuje. Ponad 50 000 studentów już tu się uczy – stworzone, byś uczył się szybciej i mniej stresował.